Delivery Order SPE2DB22D1106-SPE2DB25FDZN8
Award Date
2/18/25
Potential Completion Date
2/19/25
Potential Value
$40K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $32,589.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 10 mg tablets, a medication used to manage diabetes. This is a firm-fixed-price delivery order contract with a completion date of May 29, 2024. The contract is not designated under any set-aside program. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $13,247.18, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 25 mg tablets, a medication used to treat type 2 diabetes. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $5,962.41, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 10 mg tablets, a medication used to manage diabetes. The contract is a firm fixed-price Delivery Order with a completion date of January 24, 2025 and is not designated as a set-aside. AmerisourceBergen, a for-profit organization, maintains an Indefinite...
This federal contract award, valued at $3,051.83, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Jardiance 10 mg tablets, a medication used to treat diabetes. The contract is a Firm Fixed Price Delivery Order with a completion date of November 1, 2023. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $12,252.60, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 25 mg tablets, a medication used to treat type 2 diabetes. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $16,844.41, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 25 mg tablets, a medication used to treat diabetes. The contract is a Firm Fixed Price Delivery Order with a completion date of February 10, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery...
This federal contract award, valued at $7,901.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 25 mg Tablets, a medication used to manage diabetes. The contract has an ultimate completion date of April 21, 2023 and is structured as a firm fixed price delivery order. The contract is not designated as a set-aside and was awarded through open...
This federal contract award, valued at $49,098.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Jardiance 25 mg tablets, a medication used for the treatment of diabetes. The contract has a firm fixed-price pricing type and a period of performance through January 31, 2025. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award, valued at $5,566.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Jardiance 10 mg tablets, a medication used to treat diabetes. This is a firm fixed-price delivery order contract with an ultimate completion date of October 31, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award, valued at $39,742.22, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Jardiance 25 mg tablets, a medication used to treat type 2 diabetes. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of June 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...